Report #2859211

Received Sep 16, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex: Female
Age: 64 yrs
State: NJ
Recovered: Not recovered
Vaccinated: Sep 5, 2025
Onset: Sep 6, 2025
Days to onset: 1
Hospital days: —

Vaccines (1)

Type	Name	Manufacturer	Dose	Lot	Route / Site
UNK	VACCINE NOT SPECIFIED (NO BRAND NAME)	UNKNOWN MANUFACTURER	UNK	—	IM

Symptoms (4)

AstheniaFatigueLip swellingPain

Symptom narrative

swollen lips; asthenia; local pain aches; fatigue; This spontaneous case was reported by a consumer and describes the occurrence of LIP SWELLING (swollen lips), ASTHENIA (asthenia), PAIN (local pain aches) and FATIGUE (fatigue) in a 64-year-old female patient who received mRNA-1273.251 (Spikevax LP.8.1 PFS) for COVID-19 prophylaxis. No Medical History information was reported. On 05-Sep-2025, the patient received dose of mRNA-1273.251 (Spikevax LP.8.1 PFS) (Intramuscular use) 1 dosage form. On 06-Sep-2025, the patient experienced LIP SWELLING (swollen lips), ASTHENIA (asthenia), PAIN (local pain aches) and FATIGUE (fatigue). At the time of the report, LIP SWELLING (swollen lips), ASTHENIA (asthenia), PAIN (local pain aches) and FATIGUE (fatigue) was resolving. The action taken with mRNA-1273.251 (Spikevax LP.8.1 PFS) (Intramuscular use) was unknown. No concomitant medications were reported. It was unknown if the patient experienced any additional symptoms/events. No treatment information was provided.